Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 6051 - 6075 of 6782 in total

3-(cyclohexylamino)propanesulfonic acid

Experimental

N-acetylserotonin

Experimental

Andarine

Andarine is a non-steroidal selective androgen receptor modulator.
Experimental

Mardepodect

Investigational

BI-836858

Investigational

RGX-111

RGX-111 is an adeno-associated virus vector AAV9 designed to deliver the α-L-iduronidase (IDUA) gene. Developed by REGENXBIO Inc., it was investigated for the treatment of mucopolysaccharidosis Type I (MPS I).
Investigational

APL-030

APL-030 is a orally-active small molecule inhibitor of GCN2.
Investigational

1,2-Di-N-Pentanoyl-Sn-Glycero-3-Dithiophosphocholine

Experimental

N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine

Experimental

1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide

Experimental

1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM

Experimental

2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL

Experimental

(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE

Experimental

2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL

Experimental

Benzoylecgonine

Benzoylecgonine is the major metabolite of cocaine. It is formed by hydrolysis of cocaine in the liver, catalysed by carboxylesterases. It is excreted in the urine of cocaine users after processing in the liver. It is the main pharmaceutical ingredient in the investigational drug Esterom, a topical solution used for...
Experimental
Illicit

(-)-menthol 1-propylene glycol carbonate

Experimental

PCO-371

PCO-371 is under investigation in clinical trial NCT02475616 (A Single Ascending Dose Study of PCO371 in Healthy Volunteers).
Investigational

Buformin

Buformin is an anti-diabetic drug of the biguanide class, chemically related to metformin and phenformin. It was withdrawn from the market in most countries due to a high risk of causing lactic acidosis.
Investigational
Withdrawn

Ociperlimab

Ociperlimab is under investigation in clinical trial NCT04866017 (A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (Ccrt) in Patients With Stage III Unresectable Non-small Cell Lung Cancer).
Investigational

Dezapelisib

Dezapelisib is under investigation in clinical trial NCT02456675 (INCB040093 and INCB040093 Combined With Itacitinib (INCB039110) in Relapsed/refractory Hodgkin Lymphoma).
Investigational

KAb201

Investigational

Melaleuca alternifolia leaf

Melaleuca alternifolia leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental

24,25-Dihydroxycholecalciferol

Investigational

CP-12

Investigational

Rodatristat ethyl

Investigational
Displaying drugs 6051 - 6075 of 6782 in total